New Prostate Cancer Study Results Reported from Department of Nuclear Medicine (Therapeutic Efficacy and Safety Results of 177lu-psma Therapy In Metastatic Castration-resistant Prostate Cancer Patients: First Experience of a Developing South...).
In: Cancer Weekly, 2023-11-07, S. 913-913
serialPeriodical
Zugriff:
Keywords: Lahore; Pakistan; Asia; Cancer; Drugs and Therapies; Enzymes and Coenzymes; Health and Medicine; Oncology; Prostate Cancer; Prostate-Specific Antigen; Prostatic Neoplasms; Therapy EN Lahore Pakistan Asia Cancer Drugs and Therapies Enzymes and Coenzymes Health and Medicine Oncology Prostate Cancer Prostate-Specific Antigen Prostatic Neoplasms Therapy 913 913 1 11/06/23 20231107 NES 231107 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. Lahore, Pakistan, Asia, Cancer, Drugs and Therapies, Enzymes and Coenzymes, Health and Medicine, Oncology, Prostate Cancer, Prostate-Specific Antigen, Prostatic Neoplasms, Therapy. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Prostate Cancer Study Results Reported from Department of Nuclear Medicine (Therapeutic Efficacy and Safety Results of 177lu-psma Therapy In Metastatic Castration-resistant Prostate Cancer Patients: First Experience of a Developing South...).
|
---|---|
Zeitschrift: | Cancer Weekly, 2023-11-07, S. 913-913 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Sonstiges: |
|